Erythropoietin: from erythropoiesis to cardioprotection

Erythropoietin: from erythropoiesis to cardioprotection

Show other versions (1)

Many of the drugs that has shown promise in the treatment of hematologic malignancies and solid tumors, associated with a high potential cardiotoxic. Within this group stand anthracyclines, identified as the type of chemotherapy most likely to cause heart damage, short or long term. With the improve...

Full description

Bibliographic Details
Main Authors: Liermis Michael Dita Salabert, Ivis Mendoza Hernández, Rafael Alejandro Gómez Baute, Elena García López, Lázaro E. de la Cruz Avilés, Aramis Núñez Quintana
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2010-08-01
Series:Medisur
Subjects:
receptores de eritropoyetina
eritropoyetina
toxicidad de medicamentos
miocardiopatías cardiotoxinas
antraciclinas/efectos adversos
Online Access:http://medisur.sld.cu/index.php/medisur/article/view/1159

Internet

http://medisur.sld.cu/index.php/medisur/article/view/1159

Similar Items